Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report

Terri S. Armstrong, Allison M. Bishof, Paul D. Brown, Martin Klein, MJB Taphoorn, Christina Theodore-Oklota

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1-12
JournalNeuro-Oncology
Volume18
DOIs
Publication statusPublished - Mar 2016

Cite this